Home / Contract Awards / Lockheed Grabs Lucrative Missile Deal; General Dynamics, Sikorsky Ink Army Deals

Lockheed Grabs Lucrative Missile Deal; General Dynamics, Sikorsky Ink Army Deals

According to the Department of Defense, “the Missile Defense Agency is awarding a contract modification valued not to exceed $298, 000, 000 to Lockheed Martin (NYSE: LMT) under contract HQ0147-07-C-0196. Under this contract modification, LMSSC will manufacture and deliver a total of 26 interceptors for the Terminal High Altitude Area Defense program, representing the first lot buy of interceptors in support of the Battery 3 and 4 procurement. The work will be managed by LMSSC, Sunnyvale, Calif., with final assembly performed at Lockheed Martin’s interceptor production facility, Pike County Operations, Troy, Ala. The period of performance is projected through June 2013.

General Dynamics (NYSE: GD) was awarded a $68, 348, 663 cost-plus-fixed-fee contract for system technical support for the Abrams tank program with an estimated completion date of Dec. 19, 2011. Work is to be performed at Sterling Heights, Mich. One bid was solicited with one received. T ACOM, Warren, Mich. is the contracting activity (W56HZV-07-C-0046; Serial #1939).

Sikorsky Aircraft was awarded a $9, 421, 225 firm-fixed-price contract for long lead parts for the UH-60M aircraft with an estimated completion date of Dec. 31, 2011. Work is to be performed at Stratford, Conn. One bid was solicited with one received. U.S. Army Contracting Command, AMCOM Contracting Center, Redstone Arsenal, Ala., is the contracting activity (W58RGZ-08-C-003; Serial #1937).

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.